1. Jatuworapruk, K. Toward a holistic tophus assessment in gout clinical trials: What lies beyond tophus count and size?. Int J Rheum Dis. 2024;27 (3):e15109. doi: 10.1111/1756-185X.15109. PubMed PMID:38450846 .
  2. Jatuworapruk, K, Grainger, R. Technology, COVID-19, and approaching the insoluble problems of gout care. Lancet Rheumatol. 2023;5 (10):e570-e571. doi: 10.1016/S2665-9913(23)00217-5. PubMed PMID:38251478 .
  3. Mongkolporn, A, Satpanich, P, Grainger, R, Jatuworapruk, K. GOUT-36 prediction rule is sensitive in predicting gout flare during COVID-19 hospitalization. Int J Rheum Dis. 2024;27 (1):e15010. doi: 10.1111/1756-185X.15010. PubMed PMID:38140784 .
  4. Jatuworapruk, K, Louthrenoo, W. Emerging therapeutic options for refractory gout. Nat Rev Rheumatol. 2024;20 (2):73-74. doi: 10.1038/s41584-023-01066-5. PubMed PMID:38102493 .
  5. Sangkamanovet, S, Saengboon, S, Thitiarayavich, P, Jatuworapruk, K. A warning before the storm: Spontaneous dissection of coronary artery and abdominal aorta in a patient with recurrent miscarriages. Int J Rheum Dis. 2024;27 (1):e14969. doi: 10.1111/1756-185X.14969. PubMed PMID:37929889 .
  6. Rodrigues, F, Ziade, N, Jatuworapruk, K, Caballero-Uribe, CV, Khursheed, T, Gupta, L et al.. The Impact of Social Media on Vaccination: A Narrative Review. J Korean Med Sci. 2023;38 (40):e326. doi: 10.3346/jkms.2023.38.e326. PubMed PMID:37846789 PubMed Central PMC10578995.
  7. Jatuworapruk, K, De Vera, R, Estrella, AM, Sollano, MHMZ, Vaidya, B, Rahman, MM et al.. The APLAR Gout Registry: A multinational collaboration to better understand people with gout in the Asia-Pacific. Int J Rheum Dis. 2023;26 (8):1432-1434. doi: 10.1111/1756-185X.14765. PubMed PMID:37527022 .
  8. Lertnawapan, R, Chonprasertsuk, S, Siramolpiwat, S, Jatuworapruk, K. Correlation between Cumulative Methotrexate Dose, Metabolic Syndrome and Hepatic Fibrosis Detected by FibroScan in Rheumatoid Arthritis Patients. Medicina (Kaunas). 2023;59 (6):. doi: 10.3390/medicina59061029. PubMed PMID:37374233 PubMed Central PMC10302919.
  9. Jatuworapruk, K, Lertnawapan, R, Watcharajittanont, N, Gupta, L. Thai rheumatology training, leadership, and gender parity in the last 3 decades: An analysis of a nation-wide database. Int J Rheum Dis. 2023;26 (10):2107-2109. doi: 10.1111/1756-185X.14768. PubMed PMID:37287371 .
  10. Jatuworapruk, K, Satpanich, P, Robinson, PC, Grainger, R. Prevalence, Risk Factors, and Outcomes of Gout Flare in Patients Hospitalized for PCR-Confirmed COVID-19: A Multicenter Retrospective Cohort Study. J Rheumatol. 2023;50 (4):556-563. doi: 10.3899/jrheum.220762. PubMed PMID:36379566 .
  11. Jatuworapruk, K, Montgomery, A, Gianfrancesco, M, Conway, R, Durcan, L, Graef, ER et al.. Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry. ACR Open Rheumatol. 2022;4 (11):948-953. doi: 10.1002/acr2.11495. PubMed PMID:36000538 PubMed Central PMC9539246.
  12. Jatuworapruk, K, Dalbeth, N. Should Low Serum Urate Be Exonerated? Untangling the Influence of Sarcopenia in Observational Studies. Arthritis Rheumatol. 2023;75 (1):23-25. doi: 10.1002/art.42322. PubMed PMID:35909237 .
  13. Jatuworapruk, K, Dalbeth, N. Are we asking the right questions about urate-lowering therapy? Comment on the 2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout. Int J Rheum Dis. 2022;25 (6):714-715. doi: 10.1111/1756-185X.14327. PubMed PMID:35485609 .
  14. Jatuworapruk, K, Grainger, R, Dalbeth, N, Taylor, WJ. Regular pre-admission urate-lowering therapy and serum urate testing are associated with a shorter hospital length of stay in people with gout: A nation-wide population-based cohort study. Int J Rheum Dis. 2022;25 (2):154-162. doi: 10.1111/1756-185X.14250. PubMed PMID:34796661 .
  15. Jatuworapruk, K. Adult-onset Still's disease preceded by influenza vaccination: Coincidence or true association?. Asian Pac J Allergy Immunol. 2021; :. doi: 10.12932/AP-100121-1033. PubMed PMID:34542302 .
  16. Jatuworapruk, K, Grainger, R, Dalbeth, N, Lertnawapan, R, Hanvivadhanakul, P, Towiwat, P et al.. The GOUT-36 prediction rule for inpatient gout flare in people with comorbid gout: derivation and external validation. Rheumatology (Oxford). 2022;61 (4):1658-1662. doi: 10.1093/rheumatology/keab590. PubMed PMID:34297058 .
  17. Jatuworapruk, K, Dalbeth, N. Explaining the natural course of gout to people living in the tropics. Int J Rheum Dis. 2021;24 (6):858-859. doi: 10.1111/1756-185X.14133. PubMed PMID:34028965 .
  18. Jatuworapruk, K. Inpatient gout flare is multifactorial: comment on "clinical characteristics and risk factors for gout flare during the postsurgical period". Adv Rheumatol. 2020;60 (1):44. doi: 10.1186/s42358-020-00147-3. PubMed PMID:32847627 .
  19. Lertnawapan, R, Jatuworapruk, K. Efficacy of febuxostat versus allopurinol and the predictors of achieving target serum urate in a cohort of Thai people with gout. Clin Rheumatol. 2021;40 (1):255-262. doi: 10.1007/s10067-020-05262-6. PubMed PMID:32607660 .
  20. Jatuworapruk, K, Grainger, R, Dalbeth, N, Taylor, WJ. Development of a prediction model for inpatient gout flares in people with comorbid gout. Ann Rheum Dis. 2020;79 (3):418-423. doi: 10.1136/annrheumdis-2019-216277. PubMed PMID:31811060 .
  21. Jatuworapruk, K, Bhoopat, L, Hanvivadhanakul, P. Clinical and immunological characteristics of antiphospholipid syndrome in an Asian population: a retrospective study. Asian Pac J Allergy Immunol. 2019;37 (3):171-178. doi: 10.12932/AP-241217-0223. PubMed PMID:29981567 .
  22. Jatuworapruk, K, Lertnawapan, R, Ratanabunjerdkul, H, Kintarak, J, Satdhabudha, O. Multifocal osteolysis with chylous polyserositis and intrathoracic vein thrombosis: a diagnostic challenge for rheumatologists. Int J Rheum Dis. 2018;21 (7):1458-1462. doi: 10.1111/1756-185X.13329. PubMed PMID:29968326 .
  23. Jatuworapruk, K. Generalized finger clubbing reveals the cause of secondary gout. QJM. 2017;110 (12):829-830. doi: 10.1093/qjmed/hcx157. PubMed PMID:29025161 .
  24. Jatuworapruk, K. Progressive Elbow Contracture and Skin Thickening Due to Dystrophic Calcification. J Clin Rheumatol. 2018;24 (1):35-36. doi: 10.1097/RHU.0000000000000601. PubMed PMID:28926463 .
  25. Jatuworapruk, K, Kattipathanapong, T, Kasitanon, N, Louthrenoo, W. Ergotism Masquerading Systemic Vasculitis. J Clin Rheumatol. 2017;23 (5):287-288. doi: 10.1097/RHU.0000000000000523. PubMed PMID:28661928 .
  26. Louthrenoo, W, Jatuworapruk, K, Lhakum, P, Pattamapaspong, N. Performance of the 2015 American College of Rheumatology/European League Against Rheumatism gout classification criteria in Thai patients. Rheumatol Int. 2017;37 (5):705-711. doi: 10.1007/s00296-017-3708-3. PubMed PMID:28349197 .
  27. Katchamart, W, Narongroeknawin, P, Chevaisrakul, P, Dechanuwong, P, Mahakkanukrauh, A, Kasitanon, N et al.. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. Int J Rheum Dis. 2017;20 (9):1142-1165. doi: 10.1111/1756-185X.12905. PubMed PMID:27452207 .
  28. Jatuworapruk, K, Lhakum, P, Pattamapaspong, N, Kasitanon, N, Wangkaew, S, Louthrenoo, W et al.. Performance of the Existing Classification Criteria for Gout in Thai Patients Presenting With Acute Arthritis. Medicine (Baltimore). 2016;95 (5):e2730. doi: 10.1097/MD.0000000000002730. PubMed PMID:26844519 PubMed Central PMC4748936.
  29. Louthrenoo, W, Hongsongkiat, S, Kasitanon, N, Wangkaew, S, Jatuworapruk, K. Effect of Antituberculous Drugs on Serum Uric Acid and Urine Uric Acid Excretion. J Clin Rheumatol. 2015;21 (7):346-8. doi: 10.1097/RHU.0000000000000297. PubMed PMID:26398460 .
  30. Jatuworapruk, K, Srichairatanakool, S, Ounjaijean, S, Kasitanon, N, Wangkaew, S, Louthrenoo, W et al.. Effects of green tea extract on serum uric acid and urate clearance in healthy individuals. J Clin Rheumatol. 2014;20 (6):310-3. doi: 10.1097/RHU.0000000000000148. PubMed PMID:25160013 .
Search PubMed